This comprehensive two-day conference will explore state-of-the-art diagnostic and therapeutic issues in patients with mood disorders.
The Fourth Annual Mood Disorders Summit will explore state of the art diagnostic and therapeutic issues in patients with mood disorders. This will include reasons for missed diagnosis, changes in DSM-5, and the effects of culture on the diagnosis and treatment. The latest advances in treating all phase of the illness, including non-pharmacological therapies, metabolic side effects of therapies and strategies to make patients active collaborators in their care will be discussed.
Venue: JW Marriott Washington, DC
November 20-21, 2020
Washington, D.C. 20004, United States